Cargando…

DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification

PURPOSE: To compare functional and anatomical results of combined phacoemulsification and dexamethasone intravitreal implant (Ozurdex; DEX-I) with standard phacoemulsification in diabetic patients with cataract. METHODS: Retrospective, comparative, cohort study. Patients with nonproliferative diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Furino, Claudio, Boscia, Francesco, Niro, Alfredo, D'Addario, Maria, Grassi, Maria O., Saglimbene, Valeria, Reibaldi, Michele, Alessio, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078110/
https://www.ncbi.nlm.nih.gov/pubmed/32897932
http://dx.doi.org/10.1097/IAE.0000000000002974
_version_ 1783685003445534720
author Furino, Claudio
Boscia, Francesco
Niro, Alfredo
D'Addario, Maria
Grassi, Maria O.
Saglimbene, Valeria
Reibaldi, Michele
Alessio, Giovanni
author_facet Furino, Claudio
Boscia, Francesco
Niro, Alfredo
D'Addario, Maria
Grassi, Maria O.
Saglimbene, Valeria
Reibaldi, Michele
Alessio, Giovanni
author_sort Furino, Claudio
collection PubMed
description PURPOSE: To compare functional and anatomical results of combined phacoemulsification and dexamethasone intravitreal implant (Ozurdex; DEX-I) with standard phacoemulsification in diabetic patients with cataract. METHODS: Retrospective, comparative, cohort study. Patients with nonproliferative diabetic retinopathy, macular edema, and cataract, treated routinely at the Eye Clinic, Azienda Ospedaliero Universitaria Policlinico, Bari, Italy with phacoemulsification associated with DEX-I (n = 23; Phaco-Dex) or standard phacoemulsification (n = 23; Phaco-alone). Best-correct visual acuity, central subfield thickness, and intraocular pressure were assessed at baseline and monthly for 3 months after surgery, and t-test was used to assess change from baseline. A multilevel regression model with an unstructured correlation-type matrix to account for repeated data measures was used for statistical analysis in and between groups. RESULTS: With Phaco-Dex, best-correct visual acuity increased significantly from the first month (P = 0.0005 vs. baseline) and remained stable at the following visits; central subfield thickness decreased significantly from Month 2 (P = 0.049 and P = 0.04 vs. baseline, respectively); at each timepoint, central subfield thickness was significantly lower in the Phaco-Dex group versus Phaco-alone. Intraocular pressure increased significantly during follow-up (P = 0.001 at Month 3 vs. baseline) but remained within the normal range. In the Phaco-alone group, best-correct visual acuity, and intraocular pressure did not show any significant changes after surgery, whereas central subfield thickness increased from Month 2 (P = 0.05 vs. baseline). CONCLUSION: In diabetic patients with macular edema and visually significant cataract, combined treatment with phacoemulsification and DEX-I seemed to be effective, safe, and superior to standard phacoemulsification considering both functional and tomographic parameters.
format Online
Article
Text
id pubmed-8078110
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Retina
record_format MEDLINE/PubMed
spelling pubmed-80781102021-05-04 DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification Furino, Claudio Boscia, Francesco Niro, Alfredo D'Addario, Maria Grassi, Maria O. Saglimbene, Valeria Reibaldi, Michele Alessio, Giovanni Retina Original Study PURPOSE: To compare functional and anatomical results of combined phacoemulsification and dexamethasone intravitreal implant (Ozurdex; DEX-I) with standard phacoemulsification in diabetic patients with cataract. METHODS: Retrospective, comparative, cohort study. Patients with nonproliferative diabetic retinopathy, macular edema, and cataract, treated routinely at the Eye Clinic, Azienda Ospedaliero Universitaria Policlinico, Bari, Italy with phacoemulsification associated with DEX-I (n = 23; Phaco-Dex) or standard phacoemulsification (n = 23; Phaco-alone). Best-correct visual acuity, central subfield thickness, and intraocular pressure were assessed at baseline and monthly for 3 months after surgery, and t-test was used to assess change from baseline. A multilevel regression model with an unstructured correlation-type matrix to account for repeated data measures was used for statistical analysis in and between groups. RESULTS: With Phaco-Dex, best-correct visual acuity increased significantly from the first month (P = 0.0005 vs. baseline) and remained stable at the following visits; central subfield thickness decreased significantly from Month 2 (P = 0.049 and P = 0.04 vs. baseline, respectively); at each timepoint, central subfield thickness was significantly lower in the Phaco-Dex group versus Phaco-alone. Intraocular pressure increased significantly during follow-up (P = 0.001 at Month 3 vs. baseline) but remained within the normal range. In the Phaco-alone group, best-correct visual acuity, and intraocular pressure did not show any significant changes after surgery, whereas central subfield thickness increased from Month 2 (P = 0.05 vs. baseline). CONCLUSION: In diabetic patients with macular edema and visually significant cataract, combined treatment with phacoemulsification and DEX-I seemed to be effective, safe, and superior to standard phacoemulsification considering both functional and tomographic parameters. Retina 2021-05 2021-04-22 /pmc/articles/PMC8078110/ /pubmed/32897932 http://dx.doi.org/10.1097/IAE.0000000000002974 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Study
Furino, Claudio
Boscia, Francesco
Niro, Alfredo
D'Addario, Maria
Grassi, Maria O.
Saglimbene, Valeria
Reibaldi, Michele
Alessio, Giovanni
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
title DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
title_full DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
title_fullStr DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
title_full_unstemmed DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
title_short DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
title_sort diabetic macular edema and cataract surgery: phacoemulsification combined with dexamethasone intravitreal implant compared with standard phacoemulsification
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078110/
https://www.ncbi.nlm.nih.gov/pubmed/32897932
http://dx.doi.org/10.1097/IAE.0000000000002974
work_keys_str_mv AT furinoclaudio diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT bosciafrancesco diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT niroalfredo diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT daddariomaria diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT grassimariao diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT saglimbenevaleria diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT reibaldimichele diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification
AT alessiogiovanni diabeticmacularedemaandcataractsurgeryphacoemulsificationcombinedwithdexamethasoneintravitrealimplantcomparedwithstandardphacoemulsification